ABOUT US Overview Milestones Accolades Board Of Directors History Social Responsibility BUSINESS Domestic :- - Marketing Divisions - In-Licensing International :- - APIs - FDFs FACILITIES R & D Centre API Plants Formulation Plants :- - Goa Plant I - Goa Plant II - Baddi - Waluj R & D Profile Functional Areas Pilot Plant PRODUCTS APIs Formulations INVESTORS Financials Annual Reports Presentations Analyst Reports Con Call Transcripts Stock Price From CMD's Desk Shareholding Pattern Corporate Policies Investor Grievances NEWSROOM Press Releases Indoco In News Industry News HR VALUES Philosophy Company Culture Careers  Financial & IR Update  News Update  Annual Report 2011-12   Indoco’s Revenues grows by 11.8% Y-o-Y - Q4 FY13 Financial Results for the Quarter and Year Ended 31st March 2013 - Q4 FY13 Management Discussion & Analysis - Q4 FY13   Indoco receives ANDA approval for Glimepiride tablets from USFDA - April 18, 2013 Suresh G. Kare to receive the 'Udyog Shree Jeevan Gaurav Sanman' on March 29, 2013 Exclusive interview of Mr. Sundeep V. Bambolkar in India Infoline – Feb 13, 2013 more »